Expression of pi3k/akt pathway in gastric cancerand its blockade suppresses tumor growth and metastasis

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 3, 2012, Pages 627-636

  Ye, B ^a   Jiang, L L ^a   Xu, H T ^b   Zhou, D W ^a   Li, Z S ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b LISHUI CENTRAL HOSPITAL   (China)

Author keywords

Growth; Metastasis; Phosphoinositide 3 kinase; Protein kinase B; RNA interference

Indexed keywords

ADENOVIRUS VECTOR; GELATINASE A; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

EID: 84868019147     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500309     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Tajima Y, Yamazaki K, Makino R, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006; 12:6469-79. (Pubitemid 44799720)
3. Michl P, Downward J. Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers. Z Gastroenterol 2005; 43:1133-9. (Pubitemid 41584815)
4. García-Rostan G, Costa AM, Pereira-Castro I, et al. Mutation of the P1K3CA gene in anaplastic thyroid cancer. Cancer Res 2005; 65:10199-207. (Pubitemid 41743711)
5. Liu JF, Zhou XK, Chen JH, Yi G, Chen HG, Ba MC, Lin SQ, Qi YC. Up-regulation of PIK3CA promotes metastasis in gastric carcinoma. World J Gastroenterol 2010; 16: 4986-91.
6. Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK, Kim HK, Kim JS, Oh SC. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 2011; 71: 7061 -70.
7. KB pathways are involved in tumor necrosis factorrelated apoptosis-inducing ligand resistance in human gastric cancer cells. MoI Med Report 2010; 3( 3): 491-6.
8. Osaki M, Kase S, Adachi K, Takeda A, Hashimoto K, Ito H. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J Cancer Res Clin Oncol 2004; 130:8-14. (Pubitemid 38161242)
9. Yu HG, Ai YW, Yu LL, et al. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer 2008; 122: 433-43.
10. Ai YW, Yu HG, Yu JP, Yang Y, Li H, Hu XW, Luo HS. Impact of PI3K/Akt/mdm2 signaling pathway on the sensitivity of gastric cancer cell line SGC7901 to doxorubicin. Zhonghua Zhong Liu Za Zhi 2008; 30: 494-7.
11. Hanahan D, Weinberg RA. The hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
12. Walker EH, Perisic O, Ried C, Stephens L, Williams RL. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 1999; 402:313-20. (Pubitemid 129516270)
13. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296:1655-7. (Pubitemid 34579158)
14. Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositoI-3-OH kinase signal transduction. Nature 1995; 376: 599-602.
15. Stephens L, Anderson K, Stokoe D, et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-depent activation of protein kinase B. Science 1998; 279:710-4. (Pubitemid 28144551)
16. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001; 411:355-65. (Pubitemid 32467045)
17. Kobayashi I, Semba S, Matsuda Y, Kuroda Y, Yokozaki H. Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma. Pathobiology 2006;73:8-17. (Pubitemid 43952601)
18. Chen YL, Law PY, Loh HH. Inhibition f PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents 2005; 5:575-89. (Pubitemid 41601056)
19. Xing CG, Zhu BS, Liu HH, et al. LY294002 induces p53-dependent apoptosis of SGC7901 gastric cancer 4 cells. Acta Pharmacol Sin 2008; 29: 489-98.
20. XingC,Zhu B, Liu H, etal. Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. Acta Biochim Biophys Sin 2008; 40:194-201. (Pubitemid 351422572)
21. Yuan LH, Xia W, Zhao XZ, et al. Inhibition of PKB/ Akt activity involved in apigenin induced apoptosis in human gastric carcinoma cells. Chinese Science Bulletin 2007; 52:2226-32. (Pubitemid 47292991)
22. Ohta T, Ohmichi M, Hayasaka T, et al. Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models. Endocrinology 2006; 147: 1761-9.
23. Gupta AK, Cerniglia GJ, Mick R, et al. Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002. Int J Radiât Oncol Biol Phys 2003; 56:846-53. (Pubitemid 36677381)
24. Thomas M, Owen C. Inhibition of PI-3 kinase for treating respiratory disease: good idea or bad idea? Curr Opin Pharmacol 2008; 8: 267-74.
25. Zamore PD. RNA interference: listening to the sound of silence. Nat Struct Biol 2001; 8746-51.
26. Miao GY, Lu QM, Zhang XL. Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells. World J Gastroenterol 2007; 13: 1170-4.
27. Zhang J, Zhang QY, Fu YC, et al Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Aktl and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo. Technol Cancer Res Treat 2009; 8: 467-78.
28. Czyzewska J, Guziń;ska-Ustymowicz K, Lebelt A, et al. Evaluation of proliferating markers K.i-67, PCNA in gastric cancers. Rocz Akad Med Bialymst 2004; 49: 64-6.
29. Cawston TE and Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 2006; 20:983-1002. (Pubitemid 44356460)
30. Semba S, Moriya T, Kimura W, Yamakawa M. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas. Pancreas 2003; 26:250-7. (Pubitemid 36384157)
31. Fu Y, Zhang Q, Kang C, et al. Inhibitory effects of adenovirus mediated COX-2, Aktl and PIK.3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Int J Oncol 2009; 35: 583-91.